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Microparticles are released from the endothelium under normal 
homeostatic conditions and have been shown elevated in disease 
states, most notably those characterised by endothelial dysfunction. 
The endothelium is sensitive to oxidative stress/status and vascular 
cell adhesion molecule-1 (VCAM-1) expression is upregulated 
upon activated endothelium, furthermore the presence of VCAM-1 
on microparticles is known. S100A12, a calcium binding protein 
part of the S100 family, is shown to be present on circulating 
leukocytes and is thought a sensitive marker to local inflammatory 
process, which may be driven by oxidative stress. Eight healthy 
males were subjected to breathing hypoxic air (15% O2, approxi-
mately equivalent to 3000 metres altitude) for 80 minutes in a 
temperature controlled laboratory and venous blood samples were 
processed immediately for VCAM-1 microparticles (VCAM-1 MP) 
and S100A12 association with leukocytes by flow cytometry. A 
pre-hypoxic blood sample was used for comparison. Both VCAM-1 
MP and S100A12 association with neutrophils were significantly 
elevated post hypoxic breathing later declining to levels observed in 
the pre-test samples. A similar trend was observed in both cases and 
a correlation may exist between these two markers in response to 
hypoxia. These data offer evidence using novel markers of endothe-
lial and circulating blood responses to hypoxia.
Introduction
During periods of hypoxia, cells are metabolically compromised 
resulting in cellular dysfunction that can eventually lead to cell death 
through metabolic failure. Neutrophils bound to the endothelial 
surface accelerate endothelial cell dysfunction and tissue destruc-
tion through a variety of cytotoxic mechanisms. In addition to 
physically plugging capillaries,1 activated neutrophils mediate a 
variety of harmful responses, such as production of reactive oxygen 
species (ROS), cytotoxic enzymes and cytokines.2 Many of these 
also recruit additional neutrophils and enhance their adhesive-
ness to the vascular endothelium. The attachment of neutrophils 
to the vascular endothelium is mediated by adhesion glycoprotein 
complexes expressed both on the surface of the neutrophil and on 
the surface of the endothelial cell. ROS, in large quantities, disrupt 
the redox balance of cells resulting in oxidative stress and damage to 
membrane structures (possibly leading to membrane microparticle 
release), protein damage and cause the activation of signal transduc-
tion pathways that lead to apoptosis.3
Microparticles (MP) are cell membrane fragments released into 
the circulation to a certain extent in healthy individuals under normal 
homeostatic conditions4 and release is increased under stress condi-
tions and disease. MP are released through either cellular activation 
or apoptosis.5 We recently observed a correlation between vascular 
cell adhesion molecule-1 (VCAM-1) positive MP (VCAM+ MP) 
released from the endothelium and oxidant status,6 as measured by 
thiobarbituric acid reactive substances (TBARS), which is a measure 
of lipid peroxidation. Previous to this observation, a circadian 
rhythm in VCAM+ MP was observed in healthy males, that along 
with additional data acquired within this group allowed a normal 
homoeostatic range to be established.7
VCAM-1 is an adhesion molecule, expressed on activated 
endothelium, being involved in leukocyte attachment and trans-
migration and is a therapeutic target in inflammatory disease.8 
Endothelial MP offer an insight into the state of the endothelium as 
they carry surface antigens particular to the cell of origin and further-
more these MP can be routinely analysed with specific antibodies by 
flow cytometry.5,9 The endothelium is sensitive to oxidative stress10 
and produces nitric oxide (NO) via induction of inducible nitric 
oxide synthase (iNOS) and constitutively expressed endothelial nitric 
oxide synthase (eNOS). The endothelium may become activated in 
times of oxidative stress and this can result in cellular remodelling 
and the release of MP.11 Diseases, particularly those characterised by 
endothelial dysfunction, have been shown to result in an elevated 
concentration of endothelial derived MP.5
S100A12, a calcium binding protein belonging to the S100 
family, acts as a ligand for the multiligand cell surface receptor for 
advanced glycation end products (RAGE)12 and soluble RAGE 
(sRAGE). S100 proteins have been implicated in intracellular and 
extracellular regulatory processes and been shown to mediate inflam-
matory responses.13 S100A12 is secreted by activated neutrophils 
and inflamed tissue.14 S100A12 has been shown to interact with 
RAGE present on the endothelium to trigger an activated state 
(through NFκB pathway) resulting in induction of VCAM-1 and 
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enhanced expression of intercellular adhesion 
molecule-1 (ICAM-1) in HUVECS that can 
aid in further recruitment of leukocytes to the 
injured endothelial cells.12
The aim of this study was to quantify 
the effects of oxidative stress, induced by 
breathing air equivalent to approximately 
3,000 metres (m) altitude (15% oxygen)15 
on circulating VCAM+ MP concentration, 
thus gaining an insight into the endothe-
lial response to hypoxia and furthermore to 
correlate this response with a novel stress 
marker, S100A12, associated with the circu-
lating blood cell population of neutrophils 
and monocytes.
Results
Venous blood samples were taken on 
numerous days, prior to the hypoxic breathing, 
to establish a normal range of values in healthy 
male subjects over a 24 hour (h) period. This 
data was added to our previously published 
data that demonstrated a circadian rhythm 
and resulted in an overall mean of 1350 
VCAM+ MP per microlitre (μL) of platelet 
poor plasma (PPP), with a mean coefficient of variation of 44% (n = 
190). VCAM+ MP levels are higher in the morning hours, reaching 
a minima late afternoon and again in the night. For this reason, the 
hypoxic (15% Oxygen) treatment was scheduled for 09:00, after 
which a decrease in VCAM+ MP is normally observed. There was a 
significant effect for time (F = 11.9; p < 0.001) for VCAM+ MP (Fig. 
1), where post-hypoxic breathing (11:00), there was a large increase 
from 1020 ± 263 to 3600 ± 1040 per μL PPP (p = 0.001), a value 
well outside the established normal range. Thereafter, VCAM+ MP 
decreased towards the normal range, but at 14:00 was still signifi-
cantly higher than at 08:00 (p = 0.010). After this time no significant 
changes were observed in relation to the pre-test value.
There was a significant effect for time (F = 7.3; p < 0.001) for 
TBARS (Fig. 1), where TBARS demonstrated a small non-significant 
increase from 08:00 to 14:00, and thereafter, a marked downward 
trend. TBARS at 20:00 was significantly lower than at 11:00 
(p = 0.013) and 14:00 (p = 0.029) and significantly lower at 17:00 
than 14:00 (p = 0.047).
S100A12 association with monocytes (S100A12mono) and neutro-
phils (S100A12neutro) was assessed by flow cytometry. Typical 
forward scatter/side scatter and fluorescent antibody labelling of 
neutrophils and monocytes is shown in Figure 2. There was a signifi-
cant effect for time for S100A12neutro (F = 9.1; p < 0.001) (Fig. 3), 
where a marked increase was observed immediately after hypoxic 
breathing (p < 0.001). The S100A12neutro remained elevated at 14:00 
(p = 0.044). The effect of time on S100A12mono (Fig. 3) was not 
statistically significant (F = 1.3; p = 0.29).
Figure 1. Time dependent profile for VCAM+ MP and TBARS before and after hypoxic breathing. The 
data are represented as the mean and standard error of the mean (n = 8). HB = time during which 
subjects breathed hypoxic air.
Figure 2. Typical flow cytometry profiles showing (top) forward scatter/
side scatter with Netrophils and monocytes gated accordingly and (bottom) 
fluorescence profiles showing gated (black) neutrophils and (grey) monocytes 
incubated with either (filled) goat serum or (line) anti-human EN-RAGE.
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expression.19 Increased serum concentrations of 
S100A12 have been shown in patients with severe 
bacterial infections.20 Furthermore, serum S100A12 
maybe of use as a diagnostic marker in inflammatory 
bowel disease,21 arthritis22 and asthma.23 In inflam-
matory disease high concentrations of S100A12 have 
also been shown at local sites of inflammation such 
as synovial fluid,24 inflamed bowel mucosa25 and 
atherosclerotic lesions.26
S100A12 interaction with RAGE is capable of 
 activation of endothelial, lymphocyte and 
macrophage cells directly.13 S100A12 has been 
postulated to be a novel marker of localised 
inflammatory processes in part due to its 
overexpression at local inflammatory sites.19 As 
S100A12 is a ligand for RAGE it may be postulated 
that there is either an increase in RAGE expression 
upon the neutrophil surface following hypoxia or 
a higher degree of circulating S100A12 is bound 
to the receptor. RAGE expression has previously 
been shown to be affected by hypoxia via hypoxia-
inducible factor-1.27 Interaction between RAGE and 
its ligands has also been demonstrated to upregulate 
VCAM-1 expression on endothelium and promote 
other proinflammatory pathways.28 Furthermore 
endothelial cells release RAGE specific ligands in 
response to hypoxia,29 which could account for the observed increase 
of neutrophil associated S100A12.
The amount of S100A12 associated with both neutrophils and 
monocytes appear correlated in this study, suggesting a similar 
response to hypoxia, although the increase in the S100A12mono 
subject mean was not found significant. The increase in S100A12neutro 
following hypoxic breathing suggests S100A12 may also be a 
marker of oxidative stress in the circulating blood cell population. 
A significant correlation was observed between both endothelium 
and neutrophil reaction to hypoxia via release of VCAM+ MP and 
S100A12neutro, (p = 0.044). This may be expected as both cell types 
have intrinsic roles in hypoxia (especially I/R injury) and loca-
lised inflammation, where VCAM-1 mediates firm attachment of 
neutrophils to the endothelium. A recent study found significant 
correlations between serum concentrations of advanced glycation 
products (AGE) and VCAM-1 and the soluble form of S100A12 in 
diabetic patients.30 It has already been suggested that serum levels of 
cell surface markers may in fact be MP associated and not entirely 
freely soluble,5 furthermore elevated endothelial MP concentra-
tion is established in diabetes.31 Therefore these data30 may well 
include VCAM+ MP released from dysfunctional endothelium in 
diabetic patients and their correlation with S100A12, as observed in 
the present study. In addition advanced oxidation protein products 
have recently been shown to induce overexpression of VCAM-1 on 
endothelial cells via S100A12 mediated signalling.32,33 Induction of 
ROS generation and VCAM-1 expression was effectively prevented 
by blocking S100A12 binding to the endothelial surface.32
The effects of hypoxia on the vasculature are well characterised 
and here we highlight two potentially novel markers which link 
the blood response and endothelial response within healthy human 
subjects. Further research is necessary to elucidate the specific cellular 
mechanism and consequences behind these observations.
Figure 3. Time dependent profile for S100A12 expression on monocytes and neutrophils 
before and after hypoxic breathing. The data are represented as the mean and standard error 
of the mean (n = 8). HB = time during which subjects breathed hypoxic air.
Significant relationships were observed between VCAM+ MP and 
S100A12neutro (rs = 0.39; p = 0.044) and between S100A12mono and 
S100A12neutro (rs =0.74; p < 0.001).
Discussion
Endothelial MP have been proposed as a sensitive blood borne 
marker of endothelial state.4 The endothelium is known to be 
affected by oxidative stress and the subjects in this study were 
exposed to a significant oxidative stress by hypoxic breathing and 
subsequent re-oxygenation. This resulted in an increase in plasma 
TBARS, a measure of lipid peroxidation, and a marker of oxida-
tive stress. Hypoxia leads to numerous cellular responses including 
generation of ROS and production of hypoxia-inducible factor-1.16 
Hypoxic breathing led to a significant increase in circulating VCAM+ 
MP (Fig. 1), demonstrating a novel measure of endothelial response 
to hypoxia. Whether or not these MP came from localised activated 
endothelium or hypoxia mediated endothelial activation is debat-
able. Previously we have reported a circadian variation in VCAM+ 
MP,7 with an early morning peak decreasing into the afternoon. 
Conversely, the data presented here shows a large increase from early 
morning, after hypoxic breathing to levels well outside the normal 
range.
The synthesis of S100A12 by neutrophil granulocytes has been 
shown.17 The role of S100A12 has been implicated in the innate 
immune system in response to infection. The exact nature of 
S100A12 ligand interaction is unclear, it has been shown able to 
bind both itself and a range of other molecules and was suggested 
to act as a molecular chaperone in the presence of calcium.18 RAGE 
been identified as a receptor for S100A12.12 This RAGE interac-
tion leads to initiation of pro-inflammatory signalling cascades via 
MAP-Kinase and NFκB, resulting in increased adhesion molecule 
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TBARS analysis. EDTA plasma was obtained via centrifuga-
tion of the EDTA Vacuette® (10 min, 1500 xg) and stored at 
-80°Centigrade until analysed. Plasma TBARS was then analysed 
using a commercially available kit (Zeptometrix) following manufac-
turers’ instructions and are expressed as malondialdeyde equivalents.
Statistical analysis. All statistical analyses were completed using 
SPSS for Windows version 16.0 (SPSS Inc., Chicago, IL). Normality 
for each dependent variable for each time point was checked using 
Q-Q plots and deemed plausible in each instance. Sample descriptive 
statistics are reported as means and standard deviations. The effect of 
time on TBARS expression and S100A12 expression on both mono-
cytes (S100A12mono) and neutrophils (S100A12neutro) was analyzed 
using one-way analysis of variance for repeated measures. The 
Huynh-Feldt corrected p value was reported where the sphericity 
assumption was violated (as identified by a significant Mauchly’s test 
statistic). The VCAM+ MP data showed considerably less variance at 
08:00 in comparison with later time points. The VCAM+ MP data 
was therefore analyzed using a linear mixed model incorporating an 
autoregressive repeated covariance structure. Sidak post hoc pairwise 
comparisons were used in the event of significant main effects. The 
relationship between VCAM+ MP and S100A12neutro and between 
S100A12mono and S100A12neutro were analyzed using the Spearman 
correlation. Two-tailed statistical significance was as accepted as 
p < 0.05.
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Eight healthy male volunteers (18–24 years old) participated in 
this study. All subjects gave written informed consent and ethical 
approval was granted by the Departmental ethics committee at the 
University of Hull. Subjects reported to a temperature-controlled 
laboratory at 07:15 on the day of the study and a pre-test blood 
sample was drawn at 08:00. Venous blood was obtained by veni-
puncture into potassium EDTA tubes (Vacuette®, Greiner, UK) 
for analysis of both S100A12 and TBARS or sodium citrate tubes 
(Vacuette®, Greiner, UK) for MP analysis pre- and post-exposure 
according to Table 1. Exposure consisted of breathing hypoxic air 
(15% Oxygen, air mix) produced by a hypoxicator for 80 minutes 
(min), through masks. The hypoxic exposure started at 09:00 and 
lasted 80 min; 15% Oxygen is equivalent to approximately 3000 m 
altitude.15
MP quantification. Citrated blood was analysed according 
the method of Hugel et al.34 Platelet rich plasma was obtained by 
centrifugation (180 xg, 10 min) and this was further centrifuged 
(13,000 xg, 2 min) to remove platelets. The now platelet poor 
plasma 25 μL was then incubated with either Isotype matched IgG 
negative control FITC conjugate (4 μL, AbD Serotec, UK) or IgG 
VCAM-1 specific FITC conjugate (4 μL, AbD Serotec, UK) for 30 
min. Quantification was achieved by adding counting beads (25 μL, 
Caltag medsystems, UK) and 0.2 μm filtered PBS (200 μL) prior to 
flow cytometry.
S100A12 analysis. EDTA blood (100 μL) was mixed with 
Erythrolyse (2 mL, AbD Serotec, UK) to selectively lyse red blood 
cells. The white cells were then pelleted by centrifugation (400 xg, 5 
min), washed and resuspened in PBS. Cells (2 x 105) were incubated 
with either goat serum, to control for non-specific binding, or goat 
anti-human EN-RAGE antibody (RnD Systems, UK). Cells were 
incubated with antibody for one hour before washing with PBS, 
 centrifugation (400 xg, 5 min) and incubating (30 min) with a 
secondary, FITC conjugated anti-goat IgG antibody (AbD Serotec, 
UK). Cells were washed as above and resuspended in a final volume 
of 300 μL PBS prior to flow cytometry analysis.
Flow cytometry. For data acquisition a BD FACSCalibur (BD 
Biosciences, UK) was used and analysed using CellQuest software. 
For S100A12, 10,000 cells were counted and 50,000 events were 
counted for MP analysis. For S100A12 analysis leukocytes were 
gated according to forward scatter/side scatter characteristics and 
data is presented as mean fluorescence intensity (MFI) on the FL-1 
scale of the cells incubated with anti-human EN-RAGE minus the 
MFI obtained with goat serum.
Table 1 Sequence of experimental events
Time (h) Experimental event
07:15 Subjects report to laboratory
08:00 Pre-hypoxia blood sample
09:00 Hypoxic breathing initiated
10:20 Hypoxic breathing ended
11:00 1st post-exposure blood sample
14:00 2nd post-exposure blood sample
17:00 3rd post-exposure blood sample
20:00 4th post-exposure blood sample
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